NCT03172494View on ClinicalTrials.gov

A Trial Comparing Insulin Degludec/Liraglutide, Insulin Degludec, and Liraglutide in Chinese Subjects With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs (OADs)

PHASE3CompletedINTERVENTIONAL
Enrollment

720

Participants

Timeline

Start Date

May 26, 2017

Primary Completion Date

June 14, 2019

Study Completion Date

July 13, 2019

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

Insulin degludec/liraglutide

"Subcutaneously (s.c., under the skin)administration once daily in combination with metformin.~For 26 weeks."

DRUG

Insulin degludec

"Subcutaneously (s.c., under the skin)administration once daily in combination with metformin.~For 26 weeks."

DRUG

Liraglutide

"Subcutaneously (s.c., under the skin)administration once daily in combination with metformin.~For 26 weeks."

Trial Locations (36)

100071

Novo Nordisk Investigational Site, Beijing

101200

Novo Nordisk Investigational Site, Beijing

116011

Novo Nordisk Investigational Site, Dalian

130021

Novo Nordisk Investigational Site, Changchun

200025

Novo Nordisk Investigational Site, Shanghai

200040

Novo Nordisk Investigational Site, Shanghai

200072

Novo Nordisk Investigational Site, Shanghai

200080

Novo Nordisk Investigational Site, Shanghai

200123

Novo Nordisk Investigational Site, Shanghai

200240

Novo Nordisk Investigational Site, Shanghai

200336

Novo Nordisk Investigational Site, Shanghai

201200

Novo Nordisk Investigational Site, Pudong New District

210011

Novo Nordisk Investigational Site, Nanjing

210012

Novo Nordisk Investigational Site, Nanjing

210029

Novo Nordisk Investigational Site, Nanjing

212001

Novo Nordisk Investigational Site, Zhenjiang

213003

Novo Nordisk Investigational Site, Changzhou

223002

Novo Nordisk Investigational Site, Huai'an

223300

Novo Nordisk Investigational Site, Huai'an

230061

Novo Nordisk Investigational Site, Hefei

250013

Novo Nordisk Investigational Site, Jinan

300052

Novo Nordisk Investigational Site, Tianjin

330006

Novo Nordisk Investigational Site, Nanchang

350001

Novo Nordisk Investigational Site, Fuzhou

350005

Novo Nordisk Investigational Site, Fuzhou

350025

Novo Nordisk Investigational Site, Fuzhou

404000

Novo Nordisk Investigational Site, Chongqing

510080

Novo Nordisk Investigational Site, Guangzhou

510120

Novo Nordisk Investigational Site, Guangzhou

510515

Novo Nordisk Investigational Site, Guangzhou

650101

Novo Nordisk Investigational Site, Kunming

710061

Novo Nordisk Investigational Site, Xi'an

750004

Novo Nordisk Investigational Site, Yinchuan

061000

Novo Nordisk Investigational Site, Cangzhou

050000

Novo Nordisk Investigational Site, Shijiazhuang

050051

Novo Nordisk Investigational Site, Shijiazhuang

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY